Antigen: Aldo-keto Reductase Family 1 Member B1
Hybridoma Cells Available: No
Antigen Species: Human
Depositor: Clinical Proteomics Technologies for Cancer
Host Species: mouse
Depositors Institution: National Cancer Institute
Positive Tested Species Reactivity: Human
Antigen Molecular Weight: 36.1 kDa
Human Protein Atlas: https://www.proteinatlas.org/ENSG00000085662-AKR1B1/antibody
Predicted Species Reactivity:
Immunogen: Recombinant Full Length Protein
Alternate Gene Names: AKR1B1; ADR; ALDR1; ALR2; AR; EC 188.8.131.52; MGC1804
Alternate Antibody Name:
Alternate Antigen Name:
Epitope Mapped: No
Myeloma Strain: P3x63Ag8.653
Epitope Location or Sequence:
Uniprot ID: P15121
Immunogen Sequence: Full-length
Entrez Gene ID: 231
Additional Characterization: https://antibodies.cancer.gov/detail/CPTC-AKR1B1-1
Antibody Registry ID: AB_2273742
Additional Information: This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabeticcomplications by catalyzing the reduction of glucose to sorbitol. There are a few putativepseudogenes for this gene, and one of them has been confirmed and mapped to chromosome 3.It functions to catalyze the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies.
Recommended Applications: ELISA, FFPE, Microarray, Western Blot
These hybridomas were created by your colleagues. Please acknowledge the hybridoma contributor and the Developmental Studies Hybridoma Bank (DSHB) in the Materials and Methods of your publications. Please email the citation to us.
For your Materials & Methods section:
CPTC-AKR1B1-1 was deposited to the DSHB by Clinical Proteomics Technologies for Cancer (DSHB Hybridoma Product CPTC-AKR1B1-1)
Storage and Handling Recommendations
Although many cell products are maintained at 4°C for years without loss of activity, shelf-life at 4°C is highly variable. For immediate use, short term storage at 4°C up to two weeks is recommended. For long term storage, divide the solution into volumes of no less than 20 ul for freezing at -20°C or -80°C. The small volume aliquot should provide sufficient reagent for short term use. Freeze-thaw cycles should be avoided. For concentrate or bioreactor products, an equal volume of glycerol, a cryoprotectant, may be added prior to freezing.
Although the optimal Ig concentration for an application varies for each product and must be optimized for each laboratory, a good starting concentration for immunohistochemistry (IHC), immunofluorescence (IF), and immunocytochemistry (ICC) is 2-5 ug/ml. For western blots, the recommended concentration range is 0.2-0.5 ug/ml.